Dennis E. Doherty

4.1k total citations · 1 hit paper
80 papers, 3.2k citations indexed

About

Dennis E. Doherty is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Dennis E. Doherty has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 27 papers in Physiology and 15 papers in Immunology. Recurrent topics in Dennis E. Doherty's work include Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers), Asthma and respiratory diseases (25 papers) and Respiratory Support and Mechanisms (14 papers). Dennis E. Doherty is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers), Asthma and respiratory diseases (25 papers) and Respiratory Support and Mechanisms (14 papers). Dennis E. Doherty collaborates with scholars based in United States, Canada and Colombia. Dennis E. Doherty's co-authors include Donna L. Bratton, Christopher Haslett, P M Henson, Peter M. Henson, David M. Mannino, Gregory P. Downey, A. Sonia Buist, P A Campbell, John Savill and Valerie A. Fadok and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Cell Biology.

In The Last Decade

Dennis E. Doherty

78 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells

1992 508 citations Valerie A. Fadok, John Savill et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dennis E. Doherty United States	30	1.2k	936	911	656	472	80	3.2k
Roger S. Thrall United States	33	1.2k 1.0×	693 0.7×	718 0.8×	599 0.9×	306 0.6×	96	3.1k
Alan R. Leff United States	35	1.5k 1.2×	1.5k 1.6×	796 0.9×	1.1k 1.6×	442 0.9×	120	4.0k
Kathleen J. Haley United States	28	1.3k 1.1×	1.2k 1.3×	1.1k 1.2×	964 1.5×	316 0.7×	61	4.3k
Annemarie van Schadewijk Netherlands	28	1.1k 0.9×	790 0.8×	717 0.8×	552 0.8×	97 0.2×	52	2.6k
Ewa Jassem Poland	27	880 0.7×	561 0.6×	349 0.4×	766 1.2×	355 0.8×	209	2.6k
Ching‐Yuang Lin Taiwan	34	560 0.5×	717 0.8×	721 0.8×	714 1.1×	276 0.6×	174	4.0k
Isabelle Vachier France	32	1.5k 1.2×	1.8k 1.9×	644 0.7×	514 0.8×	473 1.0×	120	3.3k
Saleh Al‐Muhsen Saudi Arabia	25	922 0.8×	1.2k 1.3×	1.3k 1.4×	360 0.5×	231 0.5×	87	2.9k
A P Greening United Kingdom	33	2.5k 2.0×	1.9k 2.0×	520 0.6×	462 0.7×	221 0.5×	60	3.8k
Christopher Grainge Australia	29	1.6k 1.3×	1.2k 1.3×	601 0.7×	476 0.7×	137 0.3×	86	2.8k

Countries citing papers authored by Dennis E. Doherty

Since Specialization

Citations

This map shows the geographic impact of Dennis E. Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis E. Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis E. Doherty more than expected).

Fields of papers citing papers by Dennis E. Doherty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis E. Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis E. Doherty. The network helps show where Dennis E. Doherty may publish in the future.

Co-authorship network of co-authors of Dennis E. Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis E. Doherty. A scholar is included among the top collaborators of Dennis E. Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis E. Doherty. Dennis E. Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doherty, Dennis E., et al.. (2020). Tiotropium Respimat Efficacy and Safety in Asthma: Relationship to Age. The Journal of Allergy and Clinical Immunology In Practice. 8(8). 2653–2660.e4. 7 indexed citations

Porter, Noah, et al.. (2020). Strategies to Reduce Errors Associated with 2-Component Vaccines. Pharmaceutical Medicine. 35(1). 1–9. 7 indexed citations

Máspero, Jorge, Iván Chérrez-Ojeda, Dennis E. Doherty, et al.. (2014). Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma. Respiratory Medicine. 108(9). 1355–1362. 5 indexed citations

Doherty, Dennis E., Donald P. Tashkin, Tim Harrison, et al.. (2013). Improvements in Lung Function With Tiotropium as Add-On Controller Therapy to ICS+LABA for Patients With Symptomatic Severe Asthma. CHEST Journal. 144(4). 88A–88A. 3 indexed citations

Doherty, Dennis E., et al.. (2012). Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. International Journal of COPD. 7. 57–57. 41 indexed citations

Djukanović, Ratko, Susan J. Wilson, Wendy C. Moore, et al.. (2010). Montelukast added to fluticasone propionate does not alter inflammation or outcomes. Respiratory Medicine. 104(10). 1425–1435. 8 indexed citations

Make, Barry J., Samuel L. Krachman, Ralph J. Panos, Dennis E. Doherty, & James K. Stoller. (2010). Oxygen Therapy in Advanced COPD: In Whom Does it Work?. Seminars in Respiratory and Critical Care Medicine. 31(3). 334–342. 12 indexed citations

Villiers, Willem J. de, et al.. (2007). Acute alcohol intake impairs lung inflammation by changing pro- and anti-inflammatory mediator balance. Alcohol. 41(5). 335–345. 30 indexed citations

Doherty, Dennis E. & Thomas L. Petty. (2006). Recommendations of the 6th Long-Term Oxygen Therapy Consensus Conference. Respiratory Care. 51(5). 519–525. 40 indexed citations

10.

Mannino, David M., et al.. (2006). The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort. Critical Care. 10(5). R137–R137. 33 indexed citations

11.

Doherty, Dennis E., et al.. (2006). The National Lung Health Education Program (NLHEP). Proceedings of the American Thoracic Society. 3(6). 545a–545a. 15 indexed citations

12.

Mannino, David M., Dennis E. Doherty, A. Sonia Buist, & Fernando Holguín. (2004). Global Initiative on Obstructive Lung Diseases (GOLD) classification of COPD and incident lung cancer: findings from a cohort study. CHEST Journal. 126(4). 853S–853S. 1 indexed citations

13.

Petty, Thomas L. & Dennis E. Doherty. (2004). The National Lung Health Education Program: Roots, Mission, Future Directions. Respiratory Care. 49(6). 678–683. 14 indexed citations

14.

Briggs, Dick D. & Dennis E. Doherty. (2004). Long-term pharmacologic management of patients with chronic obstructive pulmonary disease. Clinical cornerstone. 6(2). S17–S28. 6 indexed citations

15.

Qureshi, Mahboob, Joan M. Cook‐Mills, Dennis E. Doherty, & Beth A. Garvy. (2003). TNF-α-Dependent ICAM-1- and VCAM-1-Mediated Inflammatory Responses Are Delayed in Neonatal Mice Infected with Pneumocystis carinii. The Journal of Immunology. 171(9). 4700–4707. 49 indexed citations

16.

Talbert, Jeffery, et al.. (2001). Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.. PubMed. 36(2). 357–71. 124 indexed citations

17.

Bratton, Donna L., Q Hamid, Mark Boguniewicz, et al.. (1995). Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis.. Journal of Clinical Investigation. 95(1). 211–218. 114 indexed citations

18.

Lynch, David A., et al.. (1993). Correlation between High Resolution Computed Tomography and Tissue Morphometry of the Lung in Bleomycin-induced Pulmonary Fibrosis in the Rabbit. American Review of Respiratory Disease. 147(3). 730–738. 16 indexed citations

19.

Fadok, Valerie A., John Savill, Christopher Haslett, et al.. (1992). Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. The Journal of Immunology. 149(12). 4029–4035. 508 indexed citations breakdown →

20.

Doherty, Dennis E., P M Henson, & Robert A. Clark. (1990). Fibronectin fragments containing the RGDS cell-binding domain mediate monocyte migration into the rabbit lung. A potential mechanism for C5 fragment-induced monocyte lung accumulation.. Journal of Clinical Investigation. 86(4). 1065–1075. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact